David A. Estell, a Genencor researcher, received the Enzyme Engineering Award for his work on protein engineering and developing efficient proprietary technology for producing advanced biofuels. He has also initiated new technology development and holds over 70 issued U.S. patents.
Genencor calls for industry, science, and policy collaboration to develop a biobased economy driving renewable energy, fuels, and chemicals production. Key components include cultivating feedstock, developing infrastructure, and building sustainable biorefineries.
A multicenter study of over 3,000 preterm infants found that those monitored with the Heart Rate Observation System experienced a greater than 20 percent reduced mortality rate. The HeRO monitor detects early signs of distress and provides a new tool for clinical assessment.